A detailed history of Tang Capital Management LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 170,000 shares of BEAM stock, worth $4.56 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
170,000
Previous 270,000 37.04%
Holding current value
$4.56 Million
Previous $6.33 Million 34.16%
% of portfolio
0.35%
Previous 0.77%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$22.57 - $33.14 $2.26 Million - $3.31 Million
-100,000 Reduced 37.04%
170,000 $4.17 Million
Q2 2024

Aug 14, 2024

BUY
$21.22 - $32.66 $5.73 Million - $8.82 Million
270,000 New
270,000 $6.33 Million
Q4 2023

Feb 14, 2024

BUY
$17.69 - $30.76 $6.19 Million - $10.8 Million
350,000 New
350,000 $9.53 Million
Q4 2022

Feb 14, 2023

BUY
$36.73 - $51.6 $3.49 Million - $4.9 Million
95,000 New
95,000 $3.72 Million

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.89B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.